Jacob Wulff Selected Research

Glutaminase

1/2014

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacob Wulff Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2014
2	Neoplasms (Cancer) 01/2015 - 01/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2022
1	Rare Diseases (Rare Disease) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Disease Progression 01/2021
1	Glucose Intolerance 01/2015
1	Inflammation (Inflammations) 01/2015
1	Psychotic Disorders (Schizoaffective Disorder) 09/2014
1	Septic Shock (Toxic Shock Syndrome) 07/2013
1	Sepsis (Septicemia) 07/2013

Drug/Important Bio-Agent (IBA)

2	Biological ProductsIBA 01/2022 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
1	EnzymesIBA 01/2022
1	BilirubinIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Heme (Haem)IBA 01/2021
1	NucleosidesIBA 01/2021
1	Cyclin D1IBA 01/2015
1	Bile Acids and Salts (Bile Acids)IBA 01/2015
1	LimoneneIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	N 30IBA 09/2014
1	alpha-hydroxyglutarateIBA 01/2014
1	Glutamine (L-Glutamine)FDA Link 01/2014
1	Tumor Biomarkers (Tumor Markers)IBA 01/2014
1	GlutaminaseIBA 01/2014
1	ProteomeIBA 07/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2014
1	Adjuvant Chemotherapy 01/2021